{
    "organizations": [],
    "uuid": "ad7fcfd3da51ca17e53037475362c007a3ce899d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ani-pharmaceuticals-reports-q1-gaa/brief-ani-pharmaceuticals-reports-q1-gaap-earnings-per-share-0-19-idUSASC0A0HA",
    "ord_in_thread": 0,
    "title": "BRIEF-ANI Pharmaceuticals Reports Q1 GAAP Earnings Per Share $0.19",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - ANI Pharmaceuticals Inc:\n* ANI PHARMACEUTICALS REPORTS FIRST QUARTER 2018 RESULTS AND REAFFIRMS GUIDANCE\n* Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.32\n* Q1 REVENUE ROSE 27 PERCENT TO $46.5 MILLION * REAFFIRMS GUIDANCE FOR FULL YEAR 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T20:55:00.000+03:00",
    "crawled": "2018-05-09T12:53:14.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ani",
        "pharmaceutical",
        "inc",
        "ani",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "result",
        "reaffirms",
        "guidance",
        "q1",
        "adjusted",
        "earnings",
        "per",
        "share",
        "q1",
        "revenue",
        "rose",
        "percent",
        "million",
        "reaffirms",
        "guidance",
        "full",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}